Fifth Third Bancorp
PCVX icon

Fifth Third Bancorp’s Vaxcyte PCVX Stock Holding History

Fifth Third Bancorp’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.1K Sell
1,379
-826
-37% -$44.9K ﹤0.01% 3048
2026
Q1 		$128K Buy
+2,205
New +$120K ﹤0.01% 2785
2025
Q2 		– Sell
-468
Closed -$17.7K – 2624
2025
Q1 		$17.7K Hold
468
– – ﹤0.01% 1804
2024
Q4 		$38.3K Hold
468
– – ﹤0.01% 1486
2024
Q3 		$53.5K Hold
468
– – ﹤0.01% 1398
2024
Q2 		$35.3K Buy
+468
New +$31.9K ﹤0.01% 1517
2023
Q3 		– Sell
-19
Closed -$949 – 2660
2023
Q2 		$949 Buy
+19
New +$901 ﹤0.01% 2517

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Fifth Third Bancorp's PCVX Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Vaxcyte (PCVX) stake by 37% in Q2 2026, selling an estimated $44.9K and leaving 1,379 shares worth $80.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3048.

Fifth Third Bancorp first reported a position in PCVX in Q2 2023 and has held it in 7 quarters since. The position peaked at $128K in Q1 2026. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Fifth Third Bancorp held 1,379 shares of Vaxcyte worth $80.1K as of Q2 2026.
  • Fifth Third Bancorp sold 826 Vaxcyte shares in Q2 2026, an estimated $44.9K.
  • Vaxcyte made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3048 holding.
  • Fifth Third Bancorp first reported a position in Vaxcyte in Q2 2023 and has held it in 7 quarters since.
  • Fifth Third Bancorp's Vaxcyte position peaked at $128K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.